CANCER drug treatments are under scrutiny as a cause of soaring healthcare and claims costs. Current cancer patients will have to brace for changes.
Home Investments Fine-tuning MediShield Life: From 2022, cancer drug treatments must be in “positive...
- Advertisement -
Most Popular
Bank of Japan expects rising inflation to spur demand for new financial services
JAPAN needs to promote digitalisation as rising inflation and interest rates will increase demand for new financial services from households, a Bank...
